GBM66 GBM Model
GBM66, a Patient-Derived Xenograft (PDX) model, offers a unique perspective on brain cancer. Utilize this model to unravel disease mechanisms and discover innovative treatment options. PDX models like GBM66 play a pivotal role in preclinical drug discovery, enabling researchers to assess potential drug candidates in a controlled environment. GBM66 closely replicates the patient’s tumor, offering valuable insights into treatment efficacy and safety. By using GBM66, you can accelerate the development of targeted therapies for brain cancer, benefiting patients worldwide.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM66
Mouse Strain: Nu/Nu
WES: Yes
Methylation: Yes
Patient Treatment History: Yes
GBM66 Survival
Survival of orthotopic intracranial implanted GBM66 in Nu/Nu mice (n=11)
